FDA label 72e3c08c-3b1e-4e8f-b8c4-6d4495aeccbd
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
- SPL set ID
- 39e14cf5-2463-41e1-95cc-5df97b2a3052
- SPL ID
- 72e3c08c-3b1e-4e8f-b8c4-6d4495aeccbd
- Version
- 4
- Effective date
- 2020-11-11
- Source export date
- 2026-11-06
- Source partition
- 10
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-11-06/b0d9ca61dc485ebaf55e14a76d7d677668e40ef1e1978cdbcc4d73d58eba0b99/drug-label-0010-of-0014.json.zip
- Source manifest SHA-256
- 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
- Import run
- 20261108T063105Z
- Imported at
- 2026-11-08 07:48:24
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 2 matching rows.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 2 matching rows.
adverse reactions
ADVERSE REACTIONS The following local adverse reactions have been reported with corticosteroid suppositories: • Burning • Itching • Irritation • Dryness • Folliculitis • Hypopigmentation • Allergic Contact Dermatitis • Secondary Infection
adverse reactions table
<table width="75%"><col width="35%"/><col width="40%"/><tbody><tr><td styleCode="Botrule Toprule " valign="top"><list listType="unordered"><item><caption>•</caption>Burning</item><item><caption>•</caption>Itching</item><item><caption>•</caption>Irritation</item><item><caption>•</caption>Dryness</item></list></td><td styleCode="Botrule Toprule " valign="top"><list listType="unordered"><item><caption>•</caption>Folliculitis</item><item><caption>•</caption>Hypopigmentation</item><item><caption>•</caption>Allergic Contact Dermatitis</item><item><caption>•</caption>Secondary Infection</item></list></td></tr></tbody></table>
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.